NARA Discovery
Article Details
← Back to Search Results
Journal Article

Development and use of an Arctic charr cell line to study antiviral responses at extremely low temperatures

S L Semple; N T K Vo; A R Li; P H Pham; N C Bols; B Dixon
Journal of Fish Diseases · Vol. 40, Issue 10 · pp. 1423-1439 · 2017

Abstract

Arctic charr ( Salvelinus alpinus ) are the northernmost distributed freshwater fish and can grow at water temperatures as low as 0.2 °C. Other teleost species have impaired immune function at temperatures that Arctic charr thrive in, and thus, charr may maintain immune function at these temperatures. In this study, a fibroblastic cell line, named ACBA , derived from the bulbus arteriosus ( BA ) of Arctic charr was developed for use in immune studies at various temperatures. ACBA has undergone more than forty passages at 18 °C over 3 years, while showing no signs of senescence‐associated β‐galactosidase activity and producing nitric oxide. Remarkably, ACBA cells survived and maintained some mitotic activity even at 1 °C for over 3 months. At these low temperatures, ACBA also continued to produce MH class I proteins. After challenge with poly I:C, only antiviral Mx proteins were induced while MH proteins remained constant. When exposed to live viruses, ACBA was shown to permit viral infection and replication of IPNV , VHSV IV a and CSV at 14 °C. Yet at the preferred temperature of 4 °C, only VHSV IV a was shown to replicate within ACBA . This study provides evidence that Arctic charr cells can maintain immune function while also resisting infection with intracellular pathogens at low temperatures.

Bibliographic Information

JournalJournal of Fish Diseases
PublisherWiley
Publication Date2017-10-01
Publication Year2017
Volume40
Issue10
Pages1423-1439
Document TypeJournal Article
Print ISSN0140-7775
eISSN1365-2761
DOI10.1111/jfd.12615
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/13652761
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.